M-AAT | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

10,137 results for “M-AAT”

Trials

View all 4929 →

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

222 participants · First posted Jan 16, 2019

Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)

77 participants · First posted Dec 9, 2005

AAT-App Outpatient Trial

82 participants · First posted Nov 15, 2021

Drugs

View all 1790 →

AAT-730

AAT-008

AAT therapy

Organizations

View all 212 →

BATEMAN, TIMOTHY M. M. MD

United States

COSTELLO, JOHN M.

United States

Florida A&M University

United States

News

View all 3206 →

Wave Life Sciences' WVE-006 Demonstrates Durable AAT Protein Production in Alpha-1 Antitrypsin Deficiency Trial

Wave Life Sciences Achieves First Therapeutic RNA Editing in Humans with WVE-006 for AATD

Wave Life Sciences' RNA Editing Data Sparks Rally in RNA Therapy Stocks

Page 1 of 1014